EWA
TYRA icon

EverSource Wealth Advisors’s Tyra Biosciences TYRA Stock Holding History

EverSource Wealth Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41K Sell
44
-84
-66% -$2.78K ﹤0.01% 3858
2026
Q1 		$4.9K Buy
128
+86
+205% +$2.78K ﹤0.01% 3278
2025
Q4 		$1.1K Sell
42
-2
-5% -$37 ﹤0.01% 3682
2025
Q3 		$616 Buy
44
+4
+10% +$46 ﹤0.01% 3897
2025
Q2 		$383 Buy
40
+31
+344% +$295 ﹤0.01% 3957
2025
Q1 		$84 Buy
+9
New +$116 ﹤0.01% 3852

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

EverSource Wealth Advisors's TYRA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Tyra Biosciences (TYRA) stake by 66% in Q2 2026, selling an estimated $2.78K and leaving 44 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3858.

EverSource Wealth Advisors first reported a position in TYRA in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.9K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • EverSource Wealth Advisors held 44 shares of Tyra Biosciences worth $1.41K as of Q2 2026.
  • EverSource Wealth Advisors sold 84 Tyra Biosciences shares in Q2 2026, an estimated $2.78K.
  • Tyra Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3858 holding.
  • EverSource Wealth Advisors first reported a position in Tyra Biosciences in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Tyra Biosciences position peaked at $4.9K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.